EMA grants positive CHMP opinion for low-dose atropine SYD-101
CRU 2025: Exploring minimally invasive glaucoma surgeries
FDA issues Complete Response Letter to Aldeyra Therapeutics for resubmitted New Drug Application of reproxalap
Advancing presbyopia treatment through optimized design